Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML

NCT07539818 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

788

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

DRUG: Venetoclax
DRUG: Azacitidine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China